Volpara takeover by Lunit gets tick from Grant Samuel

Volpara takeover by Lunit gets tick from Grant Samuel
A technician uses Volpara's system to screen for breast cancer. (Image: Getty)
Pattrick Smellie
Directors in Wellington-headquartered health-tech firm Volpara are recommending shareholders accept a 100% takeover bid from a Korean-listed counterpart after a favourable independent valuation.ASX-listed Volpara was judged by independent valuer Grant Samuel to be worth between A67c (72c) and A82c per share, compared with the takeover from Seoul-based Lunit pitched at A$1.15.The offer represented a 47% premium to the A87cps that Volpara was trading at before the Lunit bid on Dec 14, and 55% above the weighted average share price in the month be...

More Markets

NZX 50 dips despite Fletcher Building's 4.6% gain
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

ANZ agrees to record A$240m fine for widespread misconduct
Markets

ANZ agrees to record A$240m fine for widespread misconduct

ANZ has agreed to pay the largest penalty its Australian regulator has ever issued an entity in one go, due to failings in the bank’s dealings with both the Government and its retail customers.ANZ and the Australian Securities and Investments Commission (ASIC) will ask the Federa...

Trade Window looks to boost profile with ASX listing
Markets

Trade Window looks to boost profile with ASX listing

Trade Window is moving to broaden its investor base with a secondary listing in Australia.The Auckland-based trade software firm said on Monday that with its secondary listing, it was pursuing "the goal of increasing its profile among the broad pool of investors across the Tasman...

Banks revise economic outlooks for Q2 GDP contraction
Finance

Banks revise economic outlooks for Q2 GDP contraction

Economists now see NZ's GDP contracting in Q2, but doubt a technical recession in Q3.